Compare KRRO & KVHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRRO | KVHI |
|---|---|---|
| Founded | 2014 | 1978 |
| Country | United States | United States |
| Employees | 57 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.0M | 133.0M |
| IPO Year | 2019 | 1996 |
| Metric | KRRO | KVHI |
|---|---|---|
| Price | $10.02 | $6.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $20.20 | N/A |
| AVG Volume (30 Days) | ★ 195.1K | 94.3K |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.33 |
| EPS | N/A | ★ 0.04 |
| Revenue | $6,392,000.00 | ★ $9,622,000.00 |
| Revenue This Year | N/A | $27.78 |
| Revenue Next Year | $240.00 | $36.03 |
| P/E Ratio | ★ N/A | $170.00 |
| Revenue Growth | ★ 181.46 | 3.82 |
| 52 Week Low | $5.20 | $5.09 |
| 52 Week High | $55.89 | $13.00 |
| Indicator | KRRO | KVHI |
|---|---|---|
| Relative Strength Index (RSI) | 38.09 | 39.36 |
| Support Level | $9.76 | $6.90 |
| Resistance Level | $14.50 | $7.54 |
| Average True Range (ATR) | 0.96 | 0.25 |
| MACD | -0.14 | 0.01 |
| Stochastic Oscillator | 12.80 | 21.05 |
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.